Fax: (941) 957-0038
Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma
Influence of prostatic acid phosphatase
Article first published online: 3 FEB 2003
Copyright © 2003 American Cancer Society
Volume 97, Issue 4, pages 979–983, 15 February 2003
How to Cite
Dattoli, M., Wallner, K., True, L., Cash, J. and Sorace, R. (2003), Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma. Cancer, 97: 979–983. doi: 10.1002/cncr.11154
- Issue published online: 3 FEB 2003
- Article first published online: 3 FEB 2003
- Manuscript Accepted: 25 SEP 2002
- Manuscript Revised: 16 SEP 2002
- Manuscript Received: 17 JUL 2002
- 9American Joint Committee on Cancer: manual for staging cancer, 4th edition. Lippincott: Philadelphia, 1992., , , et al.
- 10Sodium thymolphthalein monophosphate: a new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum. Clin Chem. 1998; 17: 1093–1102., , .
- 11Planned extracapsular seed placement using palladium-103 for prostate brachytherapy. J Brachyther Int. 2000; 16: 35–43., , , .
- 13Prostate cancer. In: LeibelSA, PhillipsTL, editors. Textbook of radiation oncology, 2nd edition. Philadelphia: WB Saunders, 2003., .
- 14Can extraprostatic extension be treated by permanent prostate brachytherapy using Palladium-103? An analysis based on post-implant dosimetry. Int J Radiat Oncol Biol Phys. 2000; 48 (Suppl): 72., , .
- 15Treatment margins predict two-year PSA response after Pd-103 prostate brachytherapy. Int J Radiat Oncol Biol Phys. In press., , .
- 17Supplemental beam radiation. In: DattoliM, editor. Prostate brachytherapy made complicated, 2nd ed. Seattle: SmartMedicine Press, 2001: 11.1–11.23., , .